2023
Exports
$1.64MWorld Rnk 74 / 190
Flag Rnk 201 / 1002
2023
PRODUCT COMPLEXITY IN Special Pharmaceuticals
0.53Rnk 356 / 1025
2023
Imports
$47MWorld Rnk 53 / 220
Flag Rnk 106 / 1173
2023
ECONOMIC COMPLEXITY of Ecuador
-0.85Rnk 104 / 132

About

Exports In 2023, Ecuador exported $1.64M in Special Pharmaceuticals, making it the 74th largest exporter of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 201st most exported product in Ecuador. The main destination of Special Pharmaceuticals exports from Ecuador are: Guatemala ($1.24M), Chile ($197k), United States ($83.4k), Colombia ($61.1k), and Canada ($26.1k).

The fastest growing export markets for Special Pharmaceuticals of Ecuador between 2022 and 2023 were Guatemala ($1.21M), Chile ($196k), and United States ($44.2k).

Imports In 2023, Ecuador imported $47M in Special Pharmaceuticals, becoming the 53rd largest importer of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 106th most imported product in Ecuador. Ecuador imports Special Pharmaceuticals primarily from: Brazil ($8.04M), United States ($6.61M), Peru ($4.89M), Mexico ($4.68M), and China ($3.45M).

The fastest growing import markets in Special Pharmaceuticals for Ecuador between 2022 and 2023 were China ($1.85M), Peru ($1.59M), and Italy ($884k).

COMPANIES In 2021, leading companies such as One Banana (41) were at the forefront of shipping Special Pharmaceuticals from Ecuador to the United States.

Latest Trends

December 2021

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (March 2020 - December 2021)$-3.75k(-20.4%)
IMPORT GROWTH (December 2020 - December 2021)$741k(27.2%)
MAIN DESTINATION (December 2021)Peru$14.6k

This section shows Special Pharmaceuticals's exports and imports data at subnational level for Ecuador. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Special Pharmaceuticals over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$1.64M
IMPORTS (2023)$47M
NET TRADE (2023)-$45.4M

In 2023, Ecuador exported $1.64M in Special Pharmaceuticals. The main destinations of Ecuador exports on Special Pharmaceuticals were Guatemala ($1.24M), Chile ($197k), United States ($83.4k), Colombia ($61.1k), and Canada ($26.1k).

In 2023, Ecuador imported $47M in Special Pharmaceuticals, mainly from Brazil ($8.04M), United States ($6.61M), Peru ($4.89M), Mexico ($4.68M), and China ($3.45M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Special Pharmaceuticals EXPORT MARKETS FOR Ecuador WERE (2022 - 2023):
Guatemala$1.21M (4.73k%)
Chile$196k (20.2k%)
United States$44.2k (113%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Special Pharmaceuticals BY Ecuador WERE (2022 - 2023):
Colombia-$243k (-79.9%)
Australia-$16.5k (-100%)
Bolivia-$11.3k (-100%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Ecuador's main exporting competitors in Special Pharmaceuticals were:
In 2023, Ecuador's main importing competitors in Special Pharmaceuticals were:

Explore Visualizations

Trade Value of Special Pharmaceuticals by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $65.9k
TOP IMPORT POTENTIALUnited States+ $1.65M

Special Pharmaceuticals’s highest export potential is United States. With an export gap of $65.9k.   Special Pharmaceuticals’s highest import potential is United States with an import gap of $1.65M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with